Related Experiment Video
Updated: Jul 4, 2025
08:32
Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
Published on: May 23, 2025
178
Addressing Social Risks to Accelerate Health Equity in Cancer Prevention and Control
Jean A McDougall1, Theresa A Hastert2, Dede K Teteh3
1Office of Community Outreach and Engagement, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Summary
Addressing social risks in cancer prevention and control is key to achieving cancer health equity. This review outlines current research and offers multilevel recommendations for interventions targeting social determinants of cancer inequities.
Area of Science:
- Oncology
- Public Health
- Health Equity Research
Background:
- Social risks significantly impact cancer prevention and control efforts.
- Addressing these risks is crucial for advancing cancer health equity.
- The American Society of Preventive Oncology (ASPO) Cancer Health Disparities Special Interest Group highlights the need for focused research and practice.
Purpose of the Study:
- To review the current state of science regarding social risks in oncology research and practice.
- To provide recommendations for multilevel research and interventions addressing social risks.
- To identify strategies for reducing cancer inequities stemming from social determinants.
Main Methods:
- Literature review of current research on social risks in oncology.
- Analysis of the socio-ecological model for intervention development.
- Synthesis of recommendations for research and practice across multiple levels.
Main Results:
- Current research on social risks in oncology is evolving.
- Multilevel interventions are needed to effectively address social risks.
- The socio-ecological model provides a framework for targeted interventions.
Conclusions:
- Integrating social risk assessment and intervention into oncology is essential for cancer health equity.
- Future research should focus on multilevel strategies to mitigate the impact of social risks on cancer outcomes.
- Collaborative efforts across interpersonal, organizational, community, and policy levels are required to eliminate cancer inequities.
More Related Videos
Related Concept Videos
01:25Strategies for Assessing and Addressing Confounding
101
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
101
01:21Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
01:26Levels of Health Promotion and Illness Prevention
12.6K
Health promotion allows a person to control the determinants of health, resulting in an improved health status. It enhances the quality of life and reduces premature deaths. Health promotion and illness prevention programs help people make beneficial choices to reduce the risk of disease and disabilities. There are three health promotion and illness prevention levels: primary, secondary, and tertiary prevention.
In primary prevention, actions taken before disease onset prevent the disease from...
In primary prevention, actions taken before disease onset prevent the disease from...
12.6K
01:30Cancer Vaccines
367
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
367
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K